This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Join   Fellows' Corner May 4, 2011
 
 
 

Propylthiouracil is an old but useful drug
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Propylthiouracil (6-propyl-2-thiouracil, PTU) is probably one of the oldest drugs on the market in the Western world. Its use as an antithyroid drug has been well established for nearly 70 years. It was originally developed in the search for taste-changing substances. Its goitrogenic effect in laboratory animals led to the detection of its antithyroid effect. In the United States it is currently used as a second-line agent for control of hyperthyroidism and as a first-line agent in pregnancy and routinely by some practitioners. More

Thyroid drugs may raise fracture risk in elderly
Bloomberg Businessweek    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Many seniors may be at increased risk for fractures because they take "excessive" doses of drugs used to treat thyroid problems, a new study says. The findings suggest that treatment targets may have to be modified in elderly patients with thyroid problems and that regular dose monitoring of thyroid drugs is essential into older age, the researchers said. More

Many children undergo unnecessary screening for thyroid disorders
Endocrine Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Nonspecific symptoms such as weight gain, fatigue and failure to thrive often prompt primary care providers to screen for thyroid disorders in children. However, researchers for a new study found that referrals to the pediatric endocrine clinic may not be warranted because most children with abnormal thyroid function tests did not have thyroid pathology identified. More



AstraZeneca launches thyroid cancer drug in US
Pharmaceutical Business Review    Share    Share on FacebookTwitterShare on LinkedinE-mail article
AstraZeneca has launched orphan drug vandetanib, a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable (non-operable) locally advanced or metastatic disease, in the U.S. AstraZeneca is in talks with relevant authorities on a trade name and is currently referring to the treatment by its generic name, vandetanib. More

Mammograms pose no risk to thyroid
The Times and Democrat    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Regional Medical Center has received a number of calls after a recent segment on a television program that questioned how much radiation the thyroid receives from a mammogram. According to a statement released by the American College of Radiology and the Society of Breast Imaging, the radiation dose to the thyroid from a mammogram is extremely low. More
 
 
ATA Thyroid Weekly News Briefs
ATA does not develop, exert any editorial or other control, or guarantee the accuracy, completeness, efficacy, or timeliness, of the materials, information, advertising or promotional activities ("Content") in this publication. Inclusion of Content in this publication does not constitute or imply endorsement, agreement, recommendation, or favoring by ATA of such information or the entities mentioned or promoted herein. Use of any Content appearing or referenced in this publication or obtained from advertisers is voluntary, and reliance on it should only be undertaken after an independent review by qualified experts. ATA is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use of, reference to, reliance on, or performance pursuant to such Content.

Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Julie Bernhard, Content Editor, 469.420.2647   Contribute news
This edition of the ATA Weekly News Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
April 27, 2011
April 20, 2011
April 13, 2011
April 6, 2011



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063